James R. Perry, MD, FRCPC, presenting abstract LBA2, A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677). during Plenary Session including Science of Oncology Award and Lecture

Photo Galleries

Powered by SmugMug Owner Log In